Skip to main content
SpringerLink
Log in

The Age of Onset of Schizophrenia Spectrum Disorders

  • Chapter
  • First Online:
Age of Onset of Mental Disorders

Abstract

This chapter characterises the age of onset (AOO) of schizophrenia spectrum disorders and summarises findings regarding a range of clinical and social outcomes, cognition, brain structure and mortality. The peak AOO for schizophrenia spectrum disorders is between 20 and 29 years, during which the estimated incidence among males and females was 4.15 and 1.71 per 10,000 person-years, respectively. Male gender has been linked with earlier onset age, although corresponding gender differences do not exist among those with family history and cannabis use. Early-onset schizophrenia has been linked with, for example, higher familial risk, poor premorbid social adjustment and cannabis use. In adult samples, earlier AOO was associated with worse outcome regarding hospitalisations, negative symptoms, relapses, social and occupational functioning, and global outcome. Earlier onset has also been linked with more severe outcomes in childhood and adolescence schizophrenia. In addition, early AOO has been linked with larger cognitive deficits and brain alterations. In the few existing studies, later AOO has been linked with a higher suicide rate. In all, the current study found a number of differences between patients with a different AOO. However, the studies on AOO are relative heterogeneous in methodology and have provided varying results. More good-quality studies are needed that include patients without restriction on the onset age. AOO is an important characteristic of schizophrenia that could help when examining the origin, genetic mechanism and care of schizophrenia. Understanding factors that influence AOO in schizophrenia may offer clues to aid prevention of or delaying the onset of this debilitating group of disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aleman A, Hijman R, De Haan EHF, Kahn RS. Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry. 1999;156:1358–66.

    CAS  PubMed  Google Scholar 

  • Alvarez-Jimenez M, Gleeson JF, Henry LP, Harrigan SM, Harris MG, Amminger GP, Killackey E, Yung AR, Herrman H, Jackson HJ, McGorry PD. Prediction of a single psychotic episode: a 7.5-year, prospective study in first-episode psychosis. Schizophr Res. 2011;125:236–46.

    Article  CAS  PubMed  Google Scholar 

  • Alvarez-Jimenez M, Priede A, Hetrick SE, Bendall S, Killackey E, Parker AG, McGorry PD, Gleeson JF. Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophr Res. 2012;139:116–28.

    Article  CAS  PubMed  Google Scholar 

  • Amminger GP, Leicester S, Yung AR, Phillips LJ, Berger GE, Francey SM, Yuen HP, McGorry PD. Early onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals. Schizophr Res. 2006;84:67–76.

    Article  CAS  PubMed  Google Scholar 

  • Armando M, Pontillo M, Vicari S. Psychosocial interventions for very early and early-onset schizophrenia: a review of treatment efficacy. Curr Opin Psychiatry. 2015;28:312–23.

    Article  PubMed  Google Scholar 

  • Bora E, Murray RM. Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? Schizophr Bull. 2014;40:744–55.

    Article  PubMed  Google Scholar 

  • Byrne M, Agerbo E, Mortensen PB. Family history of psychiatric disorders and age at first contact in schizophrenia: an epidemiological study. Br J Psychiatry. 2002;181(Suppl 43):19–25.

    Article  Google Scholar 

  • Castle DJ, Abel K, Takei N, Murray RM. Gender differences in schizophrenia: hormonal effect or subtypes? Schizophr Bull. 1995;21:1–12.

    Article  CAS  PubMed  Google Scholar 

  • Castle DJ, Wessely S, Howard R, Murray RM. Schizophrenia with onset at the extremes of adult life. Int J Geriatr Psychiatry. 1997;12:712–7.

    Article  CAS  PubMed  Google Scholar 

  • Challis S, Nielssen O, Harris A, Large M. Systematic meta-analysis of the risk factors for deliberate self-harm before and after treatment for first-episode psychosis. Acta Psychiatr Scand. 2013;127:442–54.

    Article  CAS  PubMed  Google Scholar 

  • Claxton M, Onwumere J, Fornells-Ambrojo M. Do family interventions improve outcomes in early psychosis? A systematic review and meta-analysis. Front Psychol. 2017;8:371.

    Article  PubMed  PubMed Central  Google Scholar 

  • Clemmensen L, Vernal DL, Steinhausen HC. A systematic review of the long–term outcome of early onset schizophrenia. BMC Psychiatry. 2012;12:150. https://doi.org/10.1186/1471-244X-12-150.

    Article  PubMed  PubMed Central  Google Scholar 

  • Compton MT, Kelley ME, Ramsay CE, Pringle M, Goulding SM, Esterberg ML, Stewart T, Walker EF. Association of pre–onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first–episode patients. Am J Psychiatry. 2009;166:1251–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Compton MT, Berez C, Walker EF. The relative importance of family history, gender, mode of onset, and age at onset in predicting clinical features of first-episode psychotic disorders. Clin Schizophr Relat Psychoses. 2017;11(3):143–50. https://doi.org/10.3371/CSRP.COBE.103114.

    Article  PubMed  Google Scholar 

  • Corey-Bloom J, Jernigan T, Archibald S, Harris MJ, Jeste DV. Quantitative magnetic resonance imaging of the brain in late-life schizophrenia. Am J Psychiatry. 1995;152:447–9.

    Article  CAS  PubMed  Google Scholar 

  • Cotton SM, Lambert M, Schimmelmann BG, Foley DL, Morley KI, McGorry PD, Conus P. Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis. Schizophr Res. 2009;114:17–24.

    Article  CAS  PubMed  Google Scholar 

  • Cotton SM, Lambert M, Schimmelmann BG, Mackinnon A, Gleeson JF, Berk M, Hides L, Chanen AM, Scott J, Schöttle D, McGorry PD, Conus P. Differences between first episode schizophrenia and schizoaffective disorder. Schizophr Res. 2013;147:169–74.

    Article  CAS  PubMed  Google Scholar 

  • DeLisi LE. The significance of age of onset for schizophrenia. Schizophr Bull. 1992;18:209–15.

    Article  CAS  PubMed  Google Scholar 

  • DeLisi LE, Hoff AL. Failure to find progressive temporal lobe volume decreases 10 years subsequent to a first episode of schizophrenia. Psychiatry Res Neuroimaging. 2005;138:265–8.

    Article  Google Scholar 

  • DeLisi LE, Tew W, Xie S, Hoff AL, Sakuma M, Kushner M, Lee G, Shedlack K, Smith AM, Grimson R. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biol Psychiatry. 1995;38:349–60.

    Article  CAS  PubMed  Google Scholar 

  • DeLisi LE, Sakuma M, Maurizio AM, Relja M, Hoff AL. Cerebral ventricular change over the first 10 years after the onset of schizophrenia. Psychiatry Res Neuroimaging. 2004;130:57–70.

    Article  Google Scholar 

  • Demjaha A, Lappin JM, Stahl D, Patel MX, MacCabe JH, Howes OD, Heslin M, Reininghaus UA, Donoghue K, Lomas B, Charalambides M, Onyejiaka A, Fearon P, Jones P, Doody G, Morgan C, Dazzan P, Murray RM. Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors. Psychol Med. 2017;47:1981–9.

    Article  CAS  PubMed  Google Scholar 

  • Di Maggio C, Martinez M, Ménard JF, Petit M, Thibaut F. Evidence of a cohort effect for age at onset of schizophrenia. Am J Psychiatry. 2001;158:489–92.

    Article  PubMed  Google Scholar 

  • Donoghue K, Doody GA, Murray RM, Jones PB, Morgan C, Dazzan P, Hart J, Mazzoncini R, Maccabe JH. Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP study. Psychiatry Res. 2014;215:528–32.

    Article  PubMed  Google Scholar 

  • Doody GA, Johnstone EC, Sanderson TL, Owens DG, Muir WJ. ‘Pfropfschizophrenie’ revisited. Schizophrenia in people with mild learning disability. Br J Psychiatry. 1998;173:145–53.

    Article  CAS  PubMed  Google Scholar 

  • Ekerholm M, Waltersson SF, Fagerberg T, Söderman E, Terenius L, Agartz I, Jönsson EG, Nyman H. Neurocognitive function in long-term treated schizophrenia: a five-year follow-up study. Psychiatry Res. 2012;200:144–52.

    Article  PubMed  Google Scholar 

  • Eranti SV, MacCabe JH, Bundy H, Murray RM. Gender difference in age at onset of schizophrenia: a meta–analysis. Psychol Med. 2013;43:155–67.

    Article  CAS  PubMed  Google Scholar 

  • Esterberg ML, Trotman HD, Holtzman C, Compton MT, Walker EF. The impact of a family history of psychosis on age–at–onset and positive and negative symptoms of schizophrenia: a meta–analysis. Schizophr Res. 2010;120:121–30.

    Article  PubMed  Google Scholar 

  • Foerster A, Lewis SW, Owen MJ, Murray RM. Low birth weight and a family history of schizophrenia predict poor premorbid functioning in psychosis. Schizophr Res. 1991;5:13–20.

    Article  CAS  PubMed  Google Scholar 

  • Fraguas D, Díaz-Caneja CM, Pina-Camacho L, Janssen J, Arango C. Progressive brain changes in children and adolescents with early–onset psychosis: a meta–analysis of longitudinal MRI studies. Schizophr Res. 2016;173:132–9.

    Article  PubMed  Google Scholar 

  • Fusar-Poli P, McGorry PD, Kane JM. Improving outcomes of first-episode psychosis: an overview. World Psychiatry. 2017;16:251–65.

    Article  PubMed  PubMed Central  Google Scholar 

  • Goldberg X, Fatjó-Vilas M, Penadés R, Miret S, Muñoz MJ, Vossen H, Fañanás L. Neurodevelopmental liability to schizophrenia: the complex mediating role of age at onset and premorbid adjustment. Schizophr Res. 2011;133:143–9.

    Article  CAS  PubMed  Google Scholar 

  • Gourion D, Goldberger C, Leroy S, Bourdel MC, Olié JP, Krebs MO. Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. Neuroreport. 2005;16:1407–10.

    Article  CAS  PubMed  Google Scholar 

  • Gunnell D, Harrison G, Rasmussen F, Fouskakis D, Tynelius P. Associations between premorbid intellectual performance, early-life exposures and early-onset schizophrenia. Cohort study. Br J Psychiatry. 2002;181:298–305.

    Article  PubMed  Google Scholar 

  • Gupta S, Rajaprabhakaran R, Arndt S, Flaum M, Andreasen NC. Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia. Schizophr Res. 1995;16:189–97.

    Article  CAS  PubMed  Google Scholar 

  • Häfner H, Maurer K, Löffler W, Riecher-Rössler A. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry. 1993;162:80–6.

    Article  PubMed  Google Scholar 

  • Hahn C, Lim HK, Lee CU. Neuroimaging findings in late-onset schizophrenia and bipolar disorder. J Geriatr Psychiatry Neurol. 2014;27:56–62.

    Article  PubMed  Google Scholar 

  • Hollis C, Rapoport J. Child and adolescent schizophrenia. In: Weinberger DR, Harrison PJ, editors. Schizophrenia. 3rd ed. Chichester: Blackwell Publishing Ltd; 2011. p. 24–46.

    Chapter  Google Scholar 

  • Howard R, Jeste DV. Late–onset schizophrenia. In: Weinberger DR, Harrison PJ, editors. Schizophrenia. 3rd ed. Chichester: Blackwell Publishing Ltd; 2011. p. 47–61.

    Chapter  Google Scholar 

  • Howard R, Rabins PV, Seeman MV, Jeste DV. Late–onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia group. Am J Psychiatry. 2000;157:172–8.

    Article  CAS  PubMed  Google Scholar 

  • Huhtaniska H, Jääskeläinen E, Hirvonen N, Remes J, Murray GK, Veijola J, Isohanni M, Miettunen J. Long-term antipsychotic use and brain changes in schizophrenia—a systematic review and meta-analysis. Hum Psychopharmacol. 2017;32:e2574. https://doi.org/10.1002/hup.2574.

    Article  CAS  Google Scholar 

  • Husa A, Moilanen J, Murray G, Marttila R, Haapea M, Rannikko I, Barnett JH, Jones P, Isohanni M, Remes AM, Koponen H, Miettunen J, Jääskeläinen E. Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort. Psychiatry Res. 2017;247:130–8.

    Article  PubMed  PubMed Central  Google Scholar 

  • Immonen J, Jääskeläinen E, Korpela H, Miettunen J. Age at onset and the outcomes of schizophrenia: systematic review and meta–analysis. Early Interv Psychiatry. 2017;11(6):453–60. https://doi.org/10.1111/eip.12412.

    Article  PubMed  PubMed Central  Google Scholar 

  • Isohanni M, Nieminen P. The determinants of therapeutic community activity at an acute patients’ psychiatric ward. Int J Ther Commun. 1990;11:139–48.

    Google Scholar 

  • Isohanni I, Jones PB, Järvelin M-R, Nieminen P, Rantakallio P, Jokelainen J, Croudace TJ, Isohanni M. Educational consequences of mental disorders treated in hospital. A 31-year follow-up of the Northern Finland 1966 Birth Cohort. Psychol Med. 2001;31:339–49.

    Article  CAS  PubMed  Google Scholar 

  • Jääskeläinen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, Veijola J, Miettunen J. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013;39:1296–306.

    Article  PubMed  Google Scholar 

  • Jääskeläinen E, Juola P, Kurtti J, Haapea M, Kyllönen M, Miettunen J, Tanskanen P, Murray GK, Huhtaniska S, Barnes A, Veijola J, Isohanni M. Associations between brain morphology and outcome in schizophrenia in a general population sample. Eur Psychiatry. 2014;29:456–62.

    Article  PubMed  Google Scholar 

  • Jeste DV, McAdams LA, Palmer BW, Braff D, Jernigan TL, Paulsen JS, Stout JC, Symonds LL, Bailey A, Heaton RK. Relationship of neuropsychological and MRI measures to age of onset of schizophrenia. Acta Psychiatr Scand. 1998;98:156–64.

    Article  CAS  PubMed  Google Scholar 

  • Jones PB. Adult mental health disorders and their age at onset. Br J Psychiatry Suppl. 2013;54:s5–10.

    Article  CAS  PubMed  Google Scholar 

  • Keefe RS, Vinogradov S, Medalia A, Silverstein SM, Bell MD, Diskinson D, Ventura J, Marder SR, Stroup T. Report from the working group conference on multisite trial design for cognitive remediation in schizophrenia. Schizophr Bull. 2011;37(Suppl 5):1057–65.

    Article  PubMed  Google Scholar 

  • Kelleher I, Keeley H, Corcoran P, Lynch F, Fitzpatrick C, Devlin N, Molloy C, Roddy S, Clarke MC, Harley M, Arseneault L, Wasserman C, Carli V, Sarchiapone M, Hoven C, Wasserman D, Cannon M. Clinicopathological significance of psychotic experiences in non–psychotic young people: evidence from four population–based studies. Br J Psychiatry. 2012;201:26–32.

    Article  PubMed  Google Scholar 

  • Kendler KS, MacLean CJ. Estimating familial effects on age at onset and liability to schizophrenia. I. Results of a large sample family study. Genet Epidemiol. 1990;7:409–17.

    Article  CAS  PubMed  Google Scholar 

  • Kirkbride JB, Fearon P, Morgan C, Dazzan P, Morgan K, Tarrant J, Lloyd T, Holloway J, Hutchinson G, Leff JP, Mallett RM, Harrison GL, Murray RM, Jones PB. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry. 2006;63:250–8.

    Article  PubMed  Google Scholar 

  • Kirov G, Jones PB, Harvey I, Lewis SW, Toone BK, Rifkin L, Sham P, Murray RM. Do obstetric complications cause the earlier age at onset in male than female schizophrenics? Schizophr Res. 1996;20:117–24.

    Article  CAS  PubMed  Google Scholar 

  • Kørner A, Lopez AG, Lauritzen L, Andersen PK, Kessing LV. Late and very-late first-contact schizophrenia and the risk of dementia—a nationwide register based study. Int J Geriatr Psychiatry. 2009;24:61–7.

    Article  PubMed  Google Scholar 

  • Kyriakopoulos M, Perez-Iglesias R, Woolley JB, Kanaan RA, Vyas NS, Barker GJ, Frangou S, McGuire PK. Effect of age at onset of schizophrenia on white matter abnormalities. Br J Psychiatry. 2009;195:346–53.

    Article  PubMed  Google Scholar 

  • Large M, Sharma S, Compton MT, Slade T, Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry. 2011;68:555–61.

    Article  PubMed  Google Scholar 

  • Macdonald EM, Hayes RL, Baglioni AJ. The quantity and quality of the social networks of young people with early psychosis compared with closely matched controls. Schizophr Res. 2000;46:25–30.

    Article  CAS  PubMed  Google Scholar 

  • McGrath JJ, Saha S, Al-Hamzawi A, Alonso J, Bromet EJ, Bruffaerts R, Caldas-de-Almeida JM, Chiu WT, de Jonge P, Fayyad J, Florescu S, Gureje O, Haro JM, Hu C, Kovess-Masfety V, Lepine JP, Lim CC, Mora ME, Navarro-Mateu F, Ochoa S, Sampson N, Scott K, Viana MC, Kessler RC. Psychotic experiences in the general population: a cross-national analysis based on 31261 respondents from 18 Countries. JAMA Psychiatry. 2015;72:697–705.

    Article  PubMed  PubMed Central  Google Scholar 

  • McGrath JJ, Saha S, Al-Hamzawi AO, Alonso J, Andrade L, Borges G, Bromet EJ, Oakley Browne M, Bruffaerts R, Caldas de Almeida JM, Fayyad J, Florescu S, de Girolamo G, Gureje O, Hu C, de Jonge P, Kovess-Masfety V, Lepine JP, Lim CC, Navarro-Mateu F, Piazza M, Sampson N, Posada-Villa J, Kendler KS, Kessler RC. Age of onset and lifetime projected risk of psychotic experiences: cross-national data from the world mental health survey. Schizophr Bull. 2016;42:933–41.

    Article  PubMed  PubMed Central  Google Scholar 

  • McGrath JJ, McLaughlin KA, Saha S, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Bruffaerts R, de Girolamo G, de Jonge P, Esan O, Florescu S, Gureje O, Haro JM, Hu C, Karam EG, Kovess-Masfety V, Lee S, Lepine JP, Lim CC, Medina-Mora ME, Mneimneh Z, Pennell BE, Piazza M, Posada-Villa J, Sampson N, Viana MC, Xavier M, Bromet EJ, Kendler KS, Kessler RC. The association between childhood adversities and subsequent first onset of psychotic experiences: a cross-national analysis of 23 998 respondents from 17 countries. Psychol Med. 2017;47:1230–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Meesters PD, Comijs HC, Smit JH, Eikelenboom P, de Haan L, Beekman AT, Stek ML. Mortality and its determinants in late-life schizophrenia: a 5-year prospective study in a Dutch catchment area. Am J Geriatr Psychiatry. 2016;24:272–7.

    Article  PubMed  Google Scholar 

  • Mitelman SA, Brickman AM, Shihabuddin L, Newmark RE, Hazlett EA, Haznedar MM, Buchsbaum MS. A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia. Neuroimage. 2007;37:449–62.

    Article  PubMed  Google Scholar 

  • Moilanen K, Veijola J, Läksy K, Mäkikyrö T, Miettunen J, Kantojärvi L, Kokkonen P, Karvonen J, Herva A, Joukamaa M, Järvelin M-R, Moring J, Jones P, Isohanni M. Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort. Soc Psychiatry Psychiatr Epidemiol. 2003;38:305–10.

    Article  PubMed  Google Scholar 

  • Newcomer JW, Leucht S. Metabolic adverse effects associated with antipsychotic medications. In: Weinberger DR, Harrison PJ, editors. Schizophrenia. 3rd ed. Oxford: Wiley-Blackwell; 2011. p. 588–97.

    Google Scholar 

  • Nicolson R, Rapoport JL. Childhood–onset schizophrenia: rare but worth studying. Biol Psychiatry. 1999;46:1418–28.

    Article  CAS  PubMed  Google Scholar 

  • Onwumere J, Bebbington P, Kuipers E. Family interventions in early psychosis: specificity and effectiveness. Epidemiol Psychiatr Sci. 2011;20:113–9.

    Article  CAS  PubMed  Google Scholar 

  • Palmer BW, Dawes SE, Heaton RK. What do we know about neuropsychological aspects of schizophrenia? Neuropsychol Rev. 2009;19:365–84.

    Article  PubMed  PubMed Central  Google Scholar 

  • Panariello F, O’Driscoll L, de Souza RP, Tiwari A, Manchia M, Kennedy J, DeLuca V. Age at onset in Canadian schizophrenia patients: admixture analysis. Schizophr Res. 2010;122:278–9.

    Article  PubMed  Google Scholar 

  • Penn DL, Waldheter EJ, Perkins DO, Mueser KT, Lieberman JA. Psychosocial treatment for first-episode psychosis: a research update. Am J Psychiatry. 2005;162:2220–32.

    Article  PubMed  Google Scholar 

  • Penttilä M, Jääskeläinen E, Hirvonen N, Isohanni M, Miettunen J. Duration of untreated psychosis as predictor of long–term outcome in schizophrenia. A systematic review and meta–analysis. Br J Psychiatry. 2014;205:88–94.

    Article  PubMed  Google Scholar 

  • Peralta V, Cuesta MJ. Delusional disorder and schizophrenia: a comparative study across multiple domains. Psychol Med. 2016;46:2829–39.

    Article  CAS  PubMed  Google Scholar 

  • Popovic D, Benabarre A, Crespo JM, Goikolea JM, González-Pinto A, Gutiérrez-Rojas L, Montes JM, Vieta E. Risk factors for suicide in schizophrenia: systematic review and clinical recommendations. Acta Psychiatr Scand. 2014;130:418–26.

    Article  CAS  PubMed  Google Scholar 

  • Rajji TK, Ismail Z, Mulsant BH. Age at onset and cognition in schizophrenia: meta–analysis. Br J Psychiatry. 2009;195:286–93.

    Article  CAS  PubMed  Google Scholar 

  • Rannikko I, Haapea M, Miettunen J, Veijola J, Murray GK, Barnett JH, Husa AP, Jones PB, Isohanni M, Jääskeläinen E. Changes in verbal learning and memory in schizophrenia and non-psychotic controls in midlife: a nine-year follow-up in the Northern Finland Birth Cohort study 1966. Psychiatry Res. 2015a;228:671–9.

    Article  PubMed  Google Scholar 

  • Rannikko I, Murray GK, Juola P, Salo H, Haapea M, Miettunen J, Veijola J, Barnett JH, Husa AP, Jones PB, Järvelin M-R, Isohanni M, Jääskeläinen E. Poor premorbid school performance, but not severity of illness, predicts cognitive decline in schizophrenia in midlife. Schizophr Res Cogn. 2015b;2:120–6.

    Article  PubMed  PubMed Central  Google Scholar 

  • Rosenfield PJ, Kleinhaus K, Opler M, Perrin M, Learned N, Goetz R, Stanford A, Messinger J, Harkavy-Friedman J, Malaspina D. Later paternal age and sex differences in schizophrenia symptoms. Schizophr Res. 2010;116:191–5.

    Article  PubMed  Google Scholar 

  • Rossi A, Bustini M, Prosperini P, Marinangeli MG, Splendiani A, Daneluzzo E, Stratta P. Neuromorphological abnormalities in schizophrenic patients with good and poor outcome. Acta Psychiatr Scand. 2000;101:161–6.

    Article  CAS  PubMed  Google Scholar 

  • Rubio-Abadal E, Ochoa S, Barajas A, Baños I, Dolz M, Sanchez B, Del Cacho N, Carlson J, Huerta-Ramos E, GENIPE Group, Usall J. Birth weight and obstetric complications determine age at onset in first episode of psychosis. J Psychiatr Res. 2015;65:108–14.

    Article  CAS  PubMed  Google Scholar 

  • Sato T, Bottlender R, Schröter A, Möller HJ. Psychopathology of early-onset versus late–onset schizophrenia revisited: an observation of 473 neuroleptic-naive patients before and after first-admission treatments. Schizophr Res. 2004;67:175–83.

    Article  PubMed  Google Scholar 

  • Scherr M, Hamann M, Schwerthöffer D, Froböse T, Vukovich R, Pitschel-Walz G, Bäuml J. Environmental risk factors and their impact on the age of onset of schizophrenia: comparing familial to non-familial schizophrenia. Nord J Psychiatry. 2012;66:107–14.

    Article  PubMed  Google Scholar 

  • Shafee R, Nanda P, Padmanabhan JL, Tandon N, Alliey-Rodriguez N, Keefe RSE, Hill SK, Bishop JR, Clementz BA, Tamminga CA, Gershon ES, Pearlson GD, Keshavan MS, Sweeney JA, Robinson EB, McCarroll SA. Higher genetic risk of schizophrenia is associated with lower cognitive performance in healthy individuals. bioRxiv. 2017;103622. https://doi.org/10.1101/103622.

  • Stepniak B, Papiol S, Hammer C, Ramin A, Everts S, Hennig L, Begemann M, Ehrenreich H. Accumulated environmental risk determining age at schizophrenia onset: a deep phenotyping-based study. Lancet Psychiatry. 2014;1:444–53.

    Article  PubMed  Google Scholar 

  • Suvisaari JM, Haukka J, Tanskanen A, Lönnqvist JK. Age at onset and outcome in schizophrenia are related to the degree of familial loading. Br J Psychiatry. 1998;173:494–500.

    Article  CAS  PubMed  Google Scholar 

  • Talaslahti T, Alanen HM, Hakko H, Isohanni M, Häkkinen U, Leinonen E. Patients with very-late-onset schizophrenia-like psychosis have higher mortality rates than elderly patients with earlier onset schizophrenia. Int J Geriatr Psychiatry. 2015;30:453–9.

    Article  PubMed  Google Scholar 

  • Thorup A, Waltoft BL, Pedersen CB, Mortensen PB, Nordentoft M. Young males have a higher risk of developing schizophrenia: a Danish register study. Psychol Med. 2007;37:479–84.

    Article  PubMed  Google Scholar 

  • Timonen MJ, Saari KM, Jokelainen JJ, Meyer-Rochow VB, Räsänen PK, Koponen HJ. Insulin resistance and schizophrenia: results from the Northern Finland 1966 Birth Cohort. Schizophr Res. 2009;113:107–8.

    Article  PubMed  Google Scholar 

  • Tonkonogy JM, Geller JL. Late-onset paranoid psychosis as a distinct clinicopathologic entity: magnetic resonance imaging data in elderly patients with paranoid psychosis of late onset and schizophrenia of early onset. Neuropsychiatry Neuropsychol Behav Neurol. 1999;12:230–5.

    CAS  PubMed  Google Scholar 

  • Vahia IV, Palmer BW, Depp C, Fellows I, Golshan S, Kraemer HC, Jeste DV. Is late-onset schizophrenia a subtype of schizophrenia? Acta Psychiatr Scand. 2010;122:414–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • van der Gaag M, Smit F, Bechdolf A, French P, Linszen DH, Yung AR, McGorry P, Cuijpers P. Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. Schizophr Res. 2013;149:56–62.

    Article  PubMed  Google Scholar 

  • van der Werf M, Hanssen M, Köhler S, Verkaaik M, Verhey FR, RISE Investigators, van Winkel R, van Os J, Allardyce J. Systematic review and collaborative recalculation of 133,693 incident cases of schizophrenia. Psychol Med. 2014;44:9–16.

    Article  PubMed  Google Scholar 

  • Verdoux H, Geddes JR, Takei N, Lawrie SM, Bovet P, Eagles JM, Heun R, McCreadie RG, McNeil TF, O’Callaghan E, Stöber G, Willinger MU, Wright P, Murray RM. Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data. Am J Psychiatry. 1997;154:1220–7.

    Article  CAS  PubMed  Google Scholar 

  • Vourdas A, Pipe R, Corrigall R, Frangou S. Increased developmental deviance and premorbid dysfunction in early onset schizophrenia. Schizophr Res. 2003;62:13–22.

    Article  PubMed  Google Scholar 

  • Vyas NS, Patel NH, Puri BK. Neurobiology and phenotypic expression in early onset schizophrenia. Early Interv Psychiatry. 2011;5:3–14.

    Article  PubMed  Google Scholar 

  • Waters F, Fernyhough C. Hallucinations: a systematic review of points of similarity and difference across diagnostic classes. Schizophr Bull. 2017;43:32–43.

    Article  PubMed  Google Scholar 

  • Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R, Murray CJ, Vos T. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575–86.

    Article  PubMed  Google Scholar 

  • WHO. The global burden of disease: 2004 update. Geneva: World Health Organization Press; 2008. http://www.who.int/healthinfo/global_burden_disease/. Accessed 29 Jun 2017.

    Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the NARSAD (National Alliance for Research on Schizophrenia & Depression): Brain and Behavior Research Fund and the Academy of Finland (#268 336, #278 286). The funders had no role in the writing of the manuscript.

Author information

Authors and Affiliations

  1. Center for Life Course Health Research, University of Oulu, Oulu, Finland

    Jouko Miettunen, Johanna Immonen, Matti Isohanni & Erika Jääskeläinen

  2. Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland

    Jouko Miettunen, Johanna Immonen & Erika Jääskeläinen

  3. Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, QLD, Australia

    John J. McGrath

  4. Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia

    John J. McGrath

  5. National Centre for Register-Based Research, Aarhus BSS, Aarhus University, Aarhus, Denmark

    John J. McGrath

  6. Department of Psychiatry, Research Unit of Clinical Neuroscience, University of Oulu, Oulu, Finland

    Erika Jääskeläinen

  7. Department of Psychiatry, Oulu University Hospital, Oulu, Finland

    Erika Jääskeläinen

Authors
  1. Jouko Miettunen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Johanna Immonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John J. McGrath
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Matti Isohanni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Erika Jääskeläinen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jouko Miettunen .

Editor information

Editors and Affiliations

  1. Unit of Psychiatric Epidemiology and Evaluation, IRCCS St John of God Clinical Research Center, Brescia, Italy

    Giovanni de Girolamo

  2. Orygen The National Centre of Excellence, University of Melbourne, Victoria, Australia

    Patrick D. McGorry

  3. Association for the Improvement of Mental Health Programmes, Geneva, Switzerland

    Norman Sartorius

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Miettunen, J., Immonen, J., McGrath, J.J., Isohanni, M., Jääskeläinen, E. (2019). The Age of Onset of Schizophrenia Spectrum Disorders. In: de Girolamo, G., McGorry, P., Sartorius, N. (eds) Age of Onset of Mental Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-72619-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-72619-9_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-72618-2

  • Online ISBN: 978-3-319-72619-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation